mRNA-Expression of KRT5 and KRT20 Defines Distinct Prognostic Subgroups of Muscle-Invasive Urothelial Bladder Cancer Correlating with Histological Variants

Multicenter Prospective Phase II Trial of Neoadjuvant Dose-Dense Gemcitabine Plus Cisplatin in Patients With Muscle-Invasive Bladder Cancer

(2018) Gopa Iyer et al.   JOURNAL OF CLINICAL ONCOLOGY

A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy

(2018) Markus Eckstein et al.   Oncotarget

Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening

(2018) Sebastien Rinaldetti et al.   Oncotarget

Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy

(2017) Roland Seiler et al.   EUROPEAN UROLOGY

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade

(2017) Dung T. Le et al.   SCIENCE

High Androgen Receptor mRNA Expression Is Independently Associated with Prolonged Cancer-Specific and Recurrence-Free Survival in Stage T1 Bladder Cancer

(2017) Danijel Sikic et al.   Translational Oncology

In stage pT1 non-muscle-invasive bladder cancer (NMIBC), high KRT20 and low KRT5 mRNA expression identify the luminal subtype and predict recurrence and survival

(2017) Johannes Breyer et al.   VIRCHOWS ARCHIV

Expression of the p53 Inhibitors MDM2 and MDM4 as Outcome Predictor in Muscle-invasive Bladder Cancer

(2016) MAXIMILIAN CHRISTIAN KRIEGMAIR et al.   ANTICANCER RESEARCH

Biological subtyping of early breast cancer: a study comparing RT-qPCR with immunohistochemistry

(2016) Ralph M. Wirtz et al.   BREAST CANCER RESEARCH AND TREATMENT

Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma

(2016) Jakob Hedegaard et al.   CANCER CELL

Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer

(2016) Charles Chuanhai Guo et al.   EUROPEAN UROLOGY

ERBB2 Expression as Potential Risk-Stratification for Early Cystectomy in Patients with pT1 Bladder Cancer and Concomitant Carcinoma in situ

(2016) Johannes Breyer et al.   UROLOGIA INTERNATIONALIS

Micropapillary morphology is an indicator of poor prognosis in patients with urothelial carcinoma treated with transurethral resection and radiochemotherapy

(2016) Simone Bertz et al.   VIRCHOWS ARCHIV

Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use

(2016) Vipulkumar Dadhania et al.   EBioMedicine

Development of a robust RNA-based classifier to accurately determine ER, PR, and HER2 status in breast cancer clinical samples

(2014) Timothy R. Wilson et al.   BREAST CANCER RESEARCH AND TREATMENT

Identification of Distinct Basal and Luminal Subtypes of Muscle-Invasive Bladder Cancer with Different Sensitivities to Frontline Chemotherapy

(2014) Woonyoung Choi et al.   CANCER CELL

The Economics of Bladder Cancer: Costs and Considerations of Caring for This Disease

(2014) Robert S. Svatek et al.   EUROPEAN UROLOGY

Comprehensive molecular characterization of urothelial bladder carcinoma

(2014)   NATURE

Optimal Reference Genes for Normalization of qRT-PCR Data from Archival Formalin-fixed, Paraffin-embedded Breast Tumors Controlling for Tumor Cell Content and Decay of mRNA

(2013) Trine Tramm et al.   DIAGNOSTIC MOLECULAR PATHOLOGY

The validation of estrogen receptor 1 mRNA expression as a predictor of outcome in patients with metastatic non-small cell lung cancer

(2013) Akin Atmaca et al.   INTERNATIONAL JOURNAL OF CANCER

Biomarkers vs conventional histological analysis to detect lymph node micrometastases in bladder cancer: a real improvement?

(2012) Cristina Gazquez et al.   BJU INTERNATIONAL

A Molecular Taxonomy for Urothelial Carcinoma

(2012) G. Sjodahl et al.   CLINICAL CANCER RESEARCH

Comprehensive molecular portraits of human breast tumours

(2012) Daniel C. Koboldt et al.   NATURE

Normal and neoplastic urothelial stem cells: getting to the root of the problem

(2012) Philip Levy Ho et al.   Nature Reviews Urology

Discrepancy between clinical and pathological stage: external validation of the impact on prognosis in an international radical cystectomy cohort

(2011) Robert S. Svatek et al.   BJU INTERNATIONAL

Global cancer statistics

(2011) Ahmedin Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

New Strategies in Muscle-Invasive Bladder Cancer: On the Road to Personalized Medicine

(2011) J. B. Shah et al.   CLINICAL CANCER RESEARCH

Neoadjuvant Systemic Therapy or Early Cystectomy? Single-center Analysis of Outcomes After Therapy for Patients With Clinically Localized Micropapillary Urothelial Carcinoma of the Bladder

(2011) Islam A. Ghoneim et al.   UROLOGY

Long-term Follow-up of Bladder Cancer Patients with Disseminated Tumour Cells in Bone Marrow

(2010) Margitta Retz et al.   EUROPEAN UROLOGY

Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors

(2010) Ju-Seog Lee et al.   JOURNAL OF CLINICAL ONCOLOGY

Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer

(2010) Wun-Jae Kim et al.   Molecular Cancer

Micropapillary urothelial carcinoma of the urinary bladder: a clinicopathological analysis of 72 cases

(2010) Eva Compérat et al.   PATHOLOGY

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

(2009) K. S. Chan et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA